| Application no. and date | 10183377.0 (espacenet) (Federated) (European Patent Register), 20040510 | | Patent/reg. no. and date | DK/EP 2371391, 20140723 | | Publication date | 20111005 | | Priority no. and date | US 469211 P, 20030508, US 557621 P, 20040329, US 557620 P, 20040329, US 557622 P, 20040329 | | EP pub. no. and date |
EP 2371391 20111005 | | Effective date | | | Applicant/owner | AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard
Redwood City, CA 94063, US | | Applicant ref. no. | P015049EPDK1 EJ/GB/Ve | | Inventor | WILLIAMS, Marna, 347 Ely Place
Palo Alto, CA 94306, US,
POWERS, David B., 77 Live Oak Avenue
Fairfax, CA 94930, US,
LIU, Gao, 1135 Phyllis Avenue
Mountain View, CA 94040, US,
Landolfi, Nicolas F., 240 Gloria Circle
Palo Alto, CA 94025, US,
Tso, Yun J., 445 Oak Grove Avenue
n°16
Menlo Park, CA 94025, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07K 14/705 (2006.01) , C07K 16/28 (2006.01) , C12N 5/20 (2006.01) | | Title | Terapeutisk anvendelse af anti-CS1-antistoffer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2016 00052 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
